Olema Pharmaceuticals
OLMA
OLMA
87 hedge funds and large institutions have $329M invested in Olema Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
+22
Holders Change %
+33.85%
% of All Funds
1.37%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
35
Increased
21
Reduced
23
Closed
13
Calls
$370K
Puts
$278K
Net Calls
+$92K
Net Calls Change
+$49K
Top Buyers
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$12.5M |
| 2 |
PBA
Paradigm Biocapital Advisors
New York
|
+$12.2M |
| 3 |
BlackRock
New York
|
+$12.1M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$5.31M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$4.18M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$7.28M |
| 2 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$6.39M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$5.36M |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$3.16M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$3.14M |
